| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.62B | 677.63M | 641.77M | 637.10M | 575.73M |
| Gross Profit | 327.48M | 298.04M | 282.69M | 255.24M | 215.65M |
| EBITDA | 175.95M | 188.79M | 129.50M | 134.65M | 101.13M |
| Net Income | 141.56M | 161.41M | 102.32M | 95.88M | 83.73M |
Balance Sheet | |||||
| Total Assets | 962.12M | 627.89M | 335.92M | 293.22M | 267.80M |
| Cash, Cash Equivalents and Short-Term Investments | 328.56M | 399.65M | 134.79M | 119.34M | 1.88M |
| Total Debt | 268.73M | 11.00K | 27.31M | 81.42M | 54.69M |
| Total Liabilities | 449.19M | 132.32M | 194.00M | 279.61M | 247.96M |
| Stockholders Equity | 512.94M | 495.56M | 156.25M | 12.13M | 16.21M |
Cash Flow | |||||
| Free Cash Flow | -194.33M | 102.16M | 70.84M | 90.71M | 133.67M |
| Operating Cash Flow | -191.98M | 106.31M | 75.35M | 91.90M | 135.01M |
| Investing Cash Flow | 28.06M | -28.40M | 3.73M | 118.58M | -52.94M |
| Financing Cash Flow | 122.29M | 157.20M | -64.10M | -82.81M | -60.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$915.47M | 10.87 | 23.35% | 9.81% | 2.06% | 2.52% | |
62 Neutral | HK$1.50B | 15.63 | 8.62% | ― | 14.29% | 142.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | HK$26.60B | 161.44 | 1.75% | ― | 12.11% | ― | |
54 Neutral | HK$685.92M | 4.27 | 29.73% | 10.95% | 140.13% | -12.36% | |
50 Neutral | HK$26.83B | -24.24 | -12.16% | ― | 31.44% | 56.19% | |
42 Neutral | HK$5.94B | -21.06 | -66.11% | ― | 18.94% | 89.36% |